Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Carmen Salvaterra (NPI 1285639336)

Field	Value
Entity Type	Individual
Organization	Carmen Salvaterra
Address	10724 Little Patuxent Pkwy
City	Columbia
State	MD
ZIP	21044
Taxonomy	Pulmonary Disease Physician
NPI Enumerated	June 16, 2005

Payer Source	Total Paid
Medicare	$8.9M
Medicaid	$0

Key Findings

Revenue concentration is extremely high: the provider’s top three Medicare codes (J0225, J0222, J2350) account for 94.6% of total Medicare revenue, with J0225 alone generating $5.9M (65.5% of Medicare revenue) and J0222 contributing $2.1M (23.0%). This concentration indicates that a small number of specialty injectable products drive the vast majority of this $8.9M Medicare footprint.

Although listed taxonomy is Pulmonary Disease Physician, the code mix shows the practice is operating largely as a high-cost specialty injectable/infusion provider: J0225 and J0222 are the two dominant revenue lines, and infusion/administration codes such as 96365, 96401, 96413, and 96415 also appear in the top code list. At the same time, pulmonary-specific testing codes (94729, 94726, 94010) and E/M codes (99214, 99215) are present but account for only a small share of revenue, suggesting infusion services are the primary business line.

This provider is effectively a single-payer operation from the claims data available: lifetime Medicare revenue is $8.9M while there is no Medicaid billing on file. The absence of Medicaid activity means payer diversification is limited and reimbursement risk is concentrated in Medicare policy and pricing for the specific high-cost injectables used.

Competitive standing for the two largest injectable codes is ambiguous: J0225 and J0222 both show “#1 of 1 providers nationally (0th percentile; no national peer volume comparison available),” which limits peer-comparison interpretation despite these codes producing the majority of revenue. For J2350 the provider ranks #56 of 105 nationally (46th percentile; typical, unremarkable volume for this code), indicating a modest, not dominant, national presence for that particular product.

There is a notable statistical outlier in lower-dollar items: J3489 (zoledronic acid, 1 mg) is reported as rank #4 of 3032 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code) even though it represents only 0.1% of Medicare revenue. This unusually high national-volume rank for a small-revenue code suggests the provider administers this drug at volumes far above typical peers, a specific operational detail worth investigating in the context of the larger infusion program.

Visit-based revenue is a small fraction of the total: 99214 generated 451 claims and $45.1K (0.5% of Medicare revenue) and other office E/M codes are present at low counts. This mix implies that face-to-face clinic visits are a secondary revenue stream relative to administration of specialty injectables and infusion services.

Ancillary infusion and vascular access capability is supported by activity in procedure codes tied to infusion logistics: 36591 (50 claims), 96375 (187 claims), and infusion add-ons such as 96415 (149 claims) appear on the top list. These entries corroborate that the practice delivers complex infusion services on site, including repeated IV access and multi-hour infusions, consistent with the high revenues from injectable therapies.

The provider has an established Medicare billing history, with NPI enumerated 2005-06-16 (~21 years ago). Combined with $8.9M in lifetime Medicare revenue and the concentrated specialty-injectable profile, this tenure suggests a long-standing, Medicare-focused practice with operational capabilities oriented to infusion and biologic drug administration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0225	Injection, vutrisiran, 1 mg	1,900	$3,080	$5.9M
J0222	Injection, patisiran, 0.1 mg	26,030	$80	$2.1M
J2350	Injection, ocrelizumab, 1 mg	12,000	$50	$540K
J2182	Injection, mepolizumab, 1 mg	9,800	$20	$225.4K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	3,300	$30	$112.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	450	$100	$45.1K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	290	$60	$17.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	330	$50	$17K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	80	$140	$11.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	100	$110	$10.7K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Carmen Salvaterra — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0225	1	10	1,900	$3,080	$5.9M
J0222	1	10	26,030	$80	$2.1M
J2350	2	10	12,000	$40	$1.5M
J2182	2	10	7,180	$20	$180.3K
Q5115	2	10	3,300	$30	$170.1K
96413	163	230	200	$110	$29.6K
99214	1,985	10,270	150	$90	$24.1K
96401	36	190	140	$60	$12.5K
99213	5,574	9,280	100	$60	$12.5K
99232	1,651	3,350	80	$60	$11.1K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Carmen Salvaterra, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Johns Hopkins Community Physicians, Inc	MD	Internal Medicine Physician	$0	$12.8M
Daniel Kim	MD	Cardiovascular Disease Physician	$440K	$0
Alan Schneider	MD	Clinical Cardiac Electrophysiology Physician	$360.1K	$0
Daniel Schwartz	MD	Cardiovascular Disease Physician	$299.9K	$0
Maryam Mohammadi	DC	Cardiovascular Disease Physician	$272.6K	$0
Mark Milner	MD	Cardiovascular Disease Physician	$267.4K	$0
Shahab Bavani	MD	Internal Medicine Physician	$260.1K	$0
Kim Goring	MD	Critical Care Medicine (Internal Medicine) Physician	$253.8K	$0
Jahanbakhsh Naghshin	VA	Pulmonary Disease Physician	$250.2K	$0
Peter Hamm	MD	Pulmonary Disease Physician	$244.6K	$0

Nearby Providers

Other providers in the same ZIP code as Carmen Salvaterra, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Psychogeriatric Services LLC	MD	Psychiatry Physician	$0	$7.5M
Edwin Zaghi Dmd PC	MD	Pediatric Dentistry	$0	$7.3M
Ellicott City Primary Care Physicians, PA	MD	Pediatrics Physician	$0	$7.1M
Patient First Maryland Medical Group PLLC	MD	Family Medicine Physician	$0	$5.1M
Maryland Oncology Hematology P.A.	MD	Hematology & Oncology Physician	$0	$4.6M
American Neuromonitoring Associates, PC	MD	Neurology Physician	$0	$4.5M
Howard County General Hospital, Inc,	MD	General Acute Care Hospital	$0	$4.5M
Andrew Mener	MD	Hematology & Oncology Physician	$3.5M	$0
Edward Lee	MD	Medical Oncology Physician	$1.9M	$0
Johns Hopkins Surgery Centers Series	MD	Ambulatory Surgical Clinic/Center	$1.6M	$14.1K

Carmen Salvaterra — Billing Profile & Reimbursement Data

Sign up for Carmen Salvaterra — Billing Profile & Reimbursement Data policy alerts

Carmen Salvaterra — Billing Profile & Reimbursement Data

Sign up for Carmen Salvaterra — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References